Clinical and pharmacokinetic study of gemcitabine (GEM) - oxaliplatin (OXA) association in metastatic or locally advanced pancreatic adenocarcinoma.

被引：0
|
作者：
Airoldi, M
Cattel, L
Passera, R
Micari, C
Ferrarato, E
Zanon, C
机构：
[1] Osped San Giovanni Ant Sede, Turin, Italy
[2] Univ Turin, Fac Farm, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2059
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [31] Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma
    Sanchez, Yamirka
    Concepcion, Martha L.
    Amador, Yohan
    Piriz, Angel
    Rabassa, Rene
    Leyva, Ariel
    Arguelles, Odalys
    Leblanch, Lisett
    Moret, Sheyla
    Rivero, Gilberto
    Vasallo, Ana L.
    Martorell, Beatriz
    Guerra, Pedro P.
    Valls, Ana R.
    Sanchez, Lisset
    Saumell, Yaimarelis
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [32] A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.
    Noel, Marcus Smith
    Philip, Philip Agop
    Tejani, Mohamedtaki Abdulaziz
    Marshall, John
    He, Aiwu Ruth
    Weinberg, Benjamin Adam
    Weiner, Louis M.
    Biswas-Baldwin, Nigel
    Hoke, Frank
    Youssoufian, Hagop
    El-Hariry, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [33] Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
    Inal, A.
    Isikdogan, A.
    Kos, T.
    Algin, E.
    Gumus, M.
    Dikilitas, M.
    Elkiran, E. T.
    Helvaci, K.
    Geredeli, C.
    Dane, F.
    Balakan, O.
    Durnali, A. Gok
    Harputluoglu, H.
    Goksel, G.
    Ozdemir, N.
    Buyukberber, S.
    Yildiz, R.
    Kaplan, M. A.
    Ozkan, M.
    Uncu, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma
    Starling, N.
    Hawkes, E. A.
    Chau, I.
    Watkins, D.
    Thomas, J.
    Webb, J.
    Brown, G.
    Thomas, K.
    Barbachano, Y.
    Oates, J.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 942 - 947
  • [35] A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
    Jo, Jung Hyun
    Jung, Dawoon E.
    Lee, Hee Seung
    Park, Soo Been
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Cho, Sangsook
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (09) : 1565 - 1577
  • [36] Phase I Dose-Finding Study of Vandetanib in Combination with Gemcitabine in Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma
    Saletti, Piercarlo
    Sessa, Cristiana
    De Dosso, Sara
    Cerny, Thomas
    Renggli, Verena
    Koeberle, Dieter
    ONCOLOGY, 2011, 81 (01) : 50 - 54
  • [37] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
    Louvet, C
    Labianca, R
    Hammel, P
    Lledo, G
    Zampino, MG
    André, T
    Zaniboni, A
    Ducreux, M
    Aitini, E
    Taïeb, J
    Faroux, R
    Lepere, C
    de Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3509 - 3516
  • [39] FOLFIRINOX for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Hisai, Hiroyuki
    Tamaki, Sakurai
    Yuuki, Ikeda
    Yutaka, Koshiba
    Masafumi, Sato
    Ryosuke, Kawasaki
    Hiroshi, Gyobu
    Etsu, Miyazaki
    Tasuku, Hirako
    Shogo, Miura
    ANNALS OF ONCOLOGY, 2015, 26 : 120 - 120
  • [40] Gemcitabine (GEM) and oxaliplatin (OHP) in the treatment of locally advanced inoperable and/or metastatic pancreatic cancer (APC). A phase II study of the gruppo oncologico dell'italia meridionale (GOIM): Final results
    Giuliani, F.
    Valerio, M. R.
    Maiello, E.
    Verderame, F.
    Pisconti, S.
    Di Seri, M.
    Misino, A.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 157 - 158
12345